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Abstract
Systemic lupus erythematosus is a complex and potentially fatal autoimmune disease, characterized by autoantibody
production and multi-organ damage. By a genome-wide association study (320 patients and 1,500 controls) and
subsequent replication altogether involving a total of 3,300 Asian SLE patients from Hong Kong, Mainland China, and
Thailand, as well as 4,200 ethnically and geographically matched controls, genetic variants in ETS1 and WDFY4 were found
to be associated with SLE (ETS1: rs1128334, P=2.33610
211, OR=1.29; WDFY4: rs7097397, P=8.15610
212, OR=1.30). ETS1
encodes for a transcription factor known to be involved in a wide range of immune functions, including Th17 cell
development and terminal differentiation of B lymphocytes. SNP rs1128334 is located in the 39-UTR of ETS1, and allelic
expression analysis from peripheral blood mononuclear cells showed significantly lower expression level from the risk allele.
WDFY4 is a conserved protein with unknown function, but is predominantly expressed in primary and secondary immune
tissues, and rs7097397 in WDFY4 changes an arginine residue to glutamine (R1816Q) in this protein. Our study also
confirmed association of the HLA locus, STAT4, TNFSF4, BLK, BANK1, IRF5, and TNFAIP3 with SLE in Asians. These new genetic
findings may help us to gain a better understanding of the disease and the functions of the genes involved.
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Introduction
Systemic lupus erythematosus (SLE) is a prototype autoim-
mune disease characterized by auto-antibody production and
multi-organ damage. Genetic factors are known to play an
important role in the disease, with the monozygotic twin
concordance rate between 20–59, and the risk for siblings of
affected individuals 30 times higher than that for the general
population [1–3]. There are also population differences for the
disease both in terms of genetic susceptibility and disease
manifestations. African Americans, Hispanics and Asians all have
higher disease prevalence than Caucasians; with Asians known
PLoS Genetics | www.plosgenetics.org 1 February 2010 | Volume 6 | Issue 2 | e1000841to have more lupus nephritis than patients of European
ancestry [4,5].
Genome-Wide Association studies (GWAS) have dramatically
changed the landscape of SLE genetics, with a pace of discovery
the field has never seen before. In less than two years time, STAT4
[6], ITGAM [7–9], BLK [8], PXK and KIAA1542 [7], BANK1 [10]
and TNFAIP3 [11,12] and several other genes have been identified
as associated with SLE [13–16]. More susceptibility loci were
reported recently in two other GWAS on this disease [17,18].
Despite varied disease prevalence and severity across different
populations, it is noteworthy that most previous studies were
conducted on patients of European ancestry with under-represen-
tation of other ethnicities. We previously examined some of the
GWAS findings from populations of European origin [19]. In
addition to confirming the association of STAT4 and BLK with
SLE in our population, our data indicated differences between the
Asian and Caucasian populations. For example, our study did not
detect any significant disease association for PXK, a result that was
later confirmed by an independent study on a Korean population
[20]. Data from our study indicated that, although the risk
alleles in ITGAM are rare in Asians (,2%), they are risk factors in
our populations and are closely related to lupus nephritis in
particular [21].
In this study, we first genotyped 320 SLE patients collected in
Hong Kong by the Illumina 610-Quad Beadchip and analyzed the
data against 1500 control individuals genotyped on the same
platform. Selected SNPs were then replicated in four independent
sample collections from Hong Kong, Shanghai and Anhui,
(China), as well as Bangkok (Thailand). Genetic variants in and
around two genes, ETS1 and WDFY4, were identified as associated
with SLE with genome-wide significance. Functional character-
ization of the risk alleles also supported potential roles of these
genetic variants in disease pathogenesis.
Results
The association of HLA, STAT4, BLK, BANK1, IRF5, TNFAIP3
with SLE
The whole-genome genotyping data was thoroughly examined
by quality control measures and by population substructure
analysis. Analysis of principal component using Eigenstrat [22] did
reveal that the samples collected in Hong Kong clustered together,
suggesting that confounding population substructure or admixture
is not a major concern if Hong Kong controls were used in
association analyses. It did indicate, however, that samples
collected in Taiwan (obtained from deCODE Genetics) and
Han Chinese in Beijing (HCB, available from HapMap) cluster
very differently from Hong Kong samples, suggesting population
substructure among Chinese living in different geographical
regions and potential pitfalls in association studies when cases
and controls are not well-matched (Figure 1).
Genome-wide association analysis confirmed significant associ-
ation of some established susceptibility genes in our population,
including SNPs in the HLA locus, STAT4, TNFSF4, BANK1,
TNFAIP3, IRF5 and BLK (Table 1 and Figure 2). Similar to the
Caucasian findings [12,23], the risk allele for rs2230926 in
TNFAIP3 is low in frequency but with a relatively large effect size
in disease association. SNP rs9271366 located between HLA-DRB1
and HLA-DQA1 is the most significantly associated SNP in the
whole genome in our study. Although the HLA locus has been
consistently shown to be the locus conferring the largest effect size
with SLE association, there is little overlap between previous
GWAS findings from populations of European ancestry and our
results. The most significant SNPs in the Caucasian data [7,8] are
Author Summary
In this study, we first conducted a genome-wide associ-
ation study in a Hong Kong Chinese population, followed
by replication in three other cohorts from Mainland China
and a cohort from Thailand, which totaled 3,300 Asian
patients and 4,200 ethnically and geographically matched
controls. We identified novel variants in ETS1 and WDFY4
associated with SLE with genome-wide significance and
confirmed the association of HLA locus, STAT4, BLK, IRF5,
BANK1, TNFSF, and IRF5 with the disease. ETS1 encodes a
critical transcription factor involved in Th17 and B cell
development. Allelic expression study showed a signifi-
cantly lower expression of ETS1 from the risk allele, which
provided functional support to the genetic findings.
WDFY4 is a huge protein with unknown function but is
predominantly expressed in primary and secondary
immune tissues, and a nonsynonymous SNP in this gene
was found to be highly associated with SLE susceptibility.
Our findings shed new light on the function of these genes
as well as the mechanism of this devastating disease.
Figure 1. Principal component analysis of Chinese samples collected in Hong Kong, Taiwan, and Beijing. The red dots denote SLE
patient samples collected in Hong Kong used in our GWAS study and the blue dots are unaffected samples from Beijing (A), Taiwan (B), and Hong
Kong (C). The data on Taiwan samples was received from deCODE Genetics; the data on Han Chinese in Beijing is available from HapMap. The data on
Hong Kong controls were from other studies in the University of Hong Kong that were genotyped by the same platform. Repeat of Eigenstrat analysis
for 20 times using randomly chosen 100,000 SNPs each time from all the available SNPs produced similar results.
doi:10.1371/journal.pgen.1000841.g001
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disease susceptibility based on our GWAS result, something worth
further pursuit in future studies. Association of STAT4, BLK, IRF5,
BANK1 and TNFSF4 with the disease has been reported in our
population previously [19,21,24,25].
To answer the question on whether there are still other genetic
variants contributing to disease susceptibility, we reexamined the
Q-Q plot comparing expected and observed P values by
removing all the SNPs in the known susceptibility loci mentioned
above. After removal of these SNPs, we still observed an excess of
association signal (Figure 3), suggesting involvement of additional
susceptibility loci for this disease. Since our GWAS involved a
limited number of patients, and is therefore prone to false positive
and false negative findings, we selected SNPs for replication
based on both their significance in GWAS results as well as the
function and expression pattern of the nearby genes. Selected
SNPs were replicated first using Sequenom genotyping on limited
number of additional samples (360 cases and 360 controls), and
variants with significant association in the Sequenom data were
then examined by TaqMan genotyping on a much expanded
sample collection from four independent cohorts. SNPs in and
around two genes, v-ets erythroblastosis virus E26 oncogene
homolog 1 (avian) (ETS1) and the WDFY family member 4
(WDFY4) regions were chosen based both on initial GWAS data
as well as their known function (in the case of ETS1) and
expression pattern (in the case of WDFY4). Table 2 displays the
Table 1. Confirmation of susceptibility genes in the Hong Kong Chinese population by GWAS.
Genes SNP CHR POSITION A1 F_A F_U A2 P OR
TNFSF4 rs1234315 1 171445086 T 0.5394 0.4678 C 1.04E-03 1.33
rs704840 1 171492818 G 0.4905 0.4204 T 1.21E-03 1.33
STAT4 rs7574865 2 191672878 T 0.4589 0.3356 G 4.22E-09 1.68
rs10168266 2 191644049 T 0.4543 0.3369 C 2.17E-08 1.64
BANK1 rs4522865 4 102934911 G 0.3801 0.4577 A 3.56E-04 0.73
rs10516487 4 102970099 T 0.1392 0.1900 C 2.82E-03 0.69
HLA-DRB1/HLA-DQA1 rs9271366 6 32694832 G 0.2231 0.1283 A 7.67E-10 1.95
HLA-DQB1/HLA-DQA2 rs9275328 6 32774800 T 0.1656 0.2594 C 5.73E-07 0.57
TNFAIP3 rs2230926 6 138237759 G 0.0599 0.0225 T 3.42E-07 2.77
rs3757173 6 138231847 C 0.0678 0.0356 T 2.08E-04 1.97
IRF5 rs729302 7 128356196 C 0.2539 0.3446 A 1.01E-05 0.65
rs4728142 7 128361203 A 0.1703 0.1201 G 6.13E-04 1.50
BLK rs2736340 8 11381382 C 0.2098 0.2974 T 8.56E-06 0.63
rs2254546 8 11381089 A 0.1877 0.2720 G 1.03E-05 0.62
A1: minor allele; F_A: minor allele frequency in cases; F_U: minor allele frequency in controls.
doi:10.1371/journal.pgen.1000841.t001
Figure 2. Confirmation of association of HLA locus, and TNFSF4, STAT4, TNFAIP3, IRF5, BLK with SLE. Shown are association results
comparing SLE patients with controls collected in Hong Kong analyzed by Plink (2log10(P-value) of SNPs). The best SNP in Chromosome 11 is around
ETS1 gene (rs6590330), which is in high LD with rs1128334. And the best SNP in Chromosome 10 is in WDFY4 (rs877819).
doi:10.1371/journal.pgen.1000841.g002
ETS1 and WDFY4 Associated with SLE in Asians
PLoS Genetics | www.plosgenetics.org 3 February 2010 | Volume 6 | Issue 2 | e1000841Figure 3. Quantile-Quantile plot of expected (x-axis) and observed (y-axis) 2log10(P value) distribution in our GWAS analysis. (A)
Considering all the available SNPs. (B) SNPs in and around HLA locus, and TNFSF4, STAT4, TNFAIP3, IRF5, BLK, as well as BANK1 were excluded from
analysis.
doi:10.1371/journal.pgen.1000841.g003
Table 2. SNPs in and around ETS1 and WDFY4 that showed significant association with SLE in the GWAS data.
SNP CHR POSITION A1 F_A F_U A2 P OR
ETS1 rs6590330 11 127816269 A 0.4401 0.3466 G 8.92E-06 1.48
rs7932088 11 127822378 T 0.3312 0.3893 G 6.24E-03 0.78
rs10893872 11 127830763 T 0.5142 0.4299 C 1.04E-04 1.40
rs4937333 11 127835730 T 0.5110 0.4279 C 1.28E-04 1.40
rs12223943 11 127900838 T 0.1009 0.1409 G 7.25E-03 0.68
WDFY4 rs10508908 10 49643864 A 0.5047 0.4356 G 1.47E-03 1.32
rs11595065 10 49647888 G 0.5142 0.4379 A 4.54E-04 1.36
rs6537575 10 49649705 T 0.4432 0.3819 C 4.08E-03 1.29
rs2947344 10 49654696 T 0.5284 0.4574 C 1.14E-03 1.33
rs2663031 10 49657309 A 0.5284 0.4574 G 1.14E-03 1.33
rs2448541 10 49684822 G 0.4416 0.3532 A 2.76E-05 1.45
rs2448539 10 49685217 A 0.2310 0.1768 C 1.49E-03 1.40
rs10857650 10 49700029 G 0.3644 0.2735 A 4.63E-06 1.52
rs877819 10 49712957 A 0.2618 0.1758 G 5.66E-07 1.66
rs7922169 10 49715462 T 0.3549 0.2678 G 9.83E-06 1.50
rs11101535 10 49734437 T 0.4669 0.3960 C 9.73E-04 1.34
rs2663049 10 49736767 C 0.3517 0.2654 T 1.12E-05 1.50
rs2663052 10 49739401 C 0.3517 0.2651 T 1.03E-05 1.50
rs2620881 10 49753117 A 0.3339 0.2609 G 2.42E-04 1.42
rs2671692 10 49767825 A 0.3281 0.2594 G 4.14E-04 1.39
rs2943244 10 49770895 C 0.2476 0.1798 A 8.10E-05 1.50
rs2663041 10 49777543 C 0.3502 0.2722 T 7.96E-05 1.44
rs11101558 10 49783035 A 0.3312 0.2631 G 4.85E-04 1.39
rs1913517 10 49789060 A 0.3328 0.2617 G 2.70E-04 1.41
rs7094610 10 49792187 C 0.3344 0.2780 A 4.44E-03 1.30
doi:10.1371/journal.pgen.1000841.t002
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value,0.01 from our GWAS data. Initial replication by
Sequenom showed consistent results with the GWAS trend for
these two genes and they were further tested in the remaining
samples.
Association of ETS1 with SLE
Making use of the remaining samples from Hong Kong not
included in GWAS, and sample collections from Shanghai and
Anhui, China, and Bangkok, Thailand, we went on to replicate
the whole-genome findings on these two loci. SNPs in ETS1 listed
in Table 2, rs12223943, rs7932088 and rs10893872, were
examined in the expanded samples. SNPs rs10893872 and
rs4937333 have absolute LD with each other, so only rs10893872
was chosen for replication. SNP rs1128334 was chosen in the
place of rs6590330 for replication due to its high LD with
rs6590330 (r
2=0.97, Figure 4) and its relative position to the
gene (39-UTR) and predicted effect on microRNA binding. For
SNPs rs12223943 and rs7932088, the association seen from
whole-genome data was inconclusive (data not shown) in the
replication stage and were not further pursued. We genotyped
rs10893872 and rs1128334 in all the samples from the four
cohorts and both were found to be highly associated with SLE
(Table 3).
Independence test by logistic regression by Plink pointed to a
major contribution from rs1128334. And indeed, the sequence
around rs1128334 has high sequence conservation among
different species (Figure 4). Haplotype analysis indicated that the
TA haplotype formed by the two SNPs (rs10893872 and
rs1128334) is the major risk haplotype, whilst the CG haplotype
is the major protective haplotype (Table 4) with other haplotypes
having low allele frequencies. Subphenotype analysis was also
performed for these SNPs, and both SNPs were found to have
larger effect sizes for patients with lupus nephritis in all four
cohorts, although no statistical significance was reached in any
cases. Analysis of other subphenotypes showed insignificant, or
inconsistent results among different cohorts.
Allelic expression of ETS1 in PBMC
Since rs1128334 is located at the 39-UTR region of the gene, it
is predicted that it may have an effect on the expression level of
ETS1. Therefore, we examined allelic expression of ETS1 gene for
the two alleles of rs1128334, ‘‘A’’ and ‘‘G’’, from healthy
individuals heterozygous for this SNP (N=33). This assay assesses
directly whether the two alleles of the SNP correlate with different
steady state mRNA levels. Pyrosequencing results from PBMC of
healthy individuals heterozygous on the SNP showed a signifi-
cantly higher expression from the ‘‘G’’ allele than from the risk
‘‘A’’ allele, with a P value,0.0001 (Figure 5).
Association of WDFY4 with SLE
Two of the SNPs in WDFY4 that showed the most significant
association with the disease in our GWAS, SNPs rs10857650
and rs877819, were selected for further replication. In addition,
three nonsynonymous SNPs in this gene not genotype by the
Illumina 610-Quad Beadchip, rs2170132 (Ser1528Pro),
Figure 4. Linkage disequilibrium and sequence conservation of SNPs in ETS1. Shown are LD for significant SNPs in and around ETS1
detected by GWAS (A), and replicated SNPs in the 39-UTR and downstream of the gene (B), and sequence conservation for sequences around SNP
rs1128334 among different species (C).
doi:10.1371/journal.pgen.1000841.g004
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selected to test for disease association, aiming at identifying
functional variants in this gene. SNPs rs2170132 and rs2292584
did not show significant difference between the cases and the
controls in the Hong Kong cohort (Table 5) and Thai samples
(data not shown) and were not further tested in other cohorts.
Genotyping results on rs10857650 using TaqMan showed
significant discordance with results from the Illumina Beadchip,
and was thus removed from further analysis.
SNP rs7097397 and rs877819 were confirmed to have
significant association with the disease (Table 3). Conditional
logistic regression test indicate that the nonsynonymous SNP
coded by rs7097397 is probably the functional variant, with
P=1.01 610
25 when controlling the effect of rs877819. Inde-
pendent contribution from rs877819 is questionable, with a P
value of 0.088 considering the effect of rs7097397 in the same
test. The two SNPs have intermediate LD (r
2=0.44, Figure 6A).
The genetic result is consistent with the fact that the arginine
residue at 1816 in WDFY4 protein is well conserved among
orthologs in different mammals (Figure 6B). Preliminary analysis
on subphenotype stratification suggests that this nonsynonymous
change may be more closely involved in male and early onset
patients in a case only analysis (onset age 12 and below vs.
above, OR=1.96, P=0.0021; male vs. female: OR=1.52,
P=0.023).
Association of the SNPs in the two genes with disease risk was
also corrected by logistic regression using age and sex as
covariates, and the associations found in this study all remain
highly significant after all the corrections.
Discussion
Several GWAS on SLE have been conducted on populations of
European ancestry [7,8], but populations of Asian or African
ancestry were seriously underrepresented. Only during the process
of submission of our current work, a GWAS study on Chinese
populations was reported [18]. Considering the population
differences in both disease prevalence and clinical manifestations,
GWAS on non-Caucasian populations may have novel findings
and help to elucidate the differences between populations.
An interesting analysis result from our GWAS data is the
difference between Hong Kong samples and samples collected in
Taiwan and Beijing, shown by principal component analysis
(Figure 1). It suggests population substructure for Chinese living in
different regions, which may cause spurious findings in association
studies when cases and controls are not well matched. With most
of the genetic variants of relatively larger effect sizes already being
identified, GWAS becomes more susceptible to effects from
mismatches between cases and controls in dealing with SNPs of
smaller effect sizes. Our analysis echoed two very recent reports
delineating population substructures in Chinese populations living
in different geographical regions [26,27].
Ets-1 is a member of the ETS family of transcription factors that
share a unique Ets DNA binding domain. They control a wide
variety of cellular processes including cell proliferation and
Table 3. SNPs showed significant association with SLE in a joint analysis of four independent Asian cohorts.
SNP Chr
Nearby
Gene
Location
relative
to gene MINOR ALLELE FREQUENCIES (MAF, %)
JOINT P
VALUE OR
95% CI
OF OR
Hong Kong Shanghai Bangkok Hefei, China
Case
N=1073
Cont
N=1742
Case
N=920
Cont
N=1053
Case
N=314
Cont
N=519
Case
N=951
Cont
N=860
rs1128334 11 ETS1 39-UTR 40.6 35.1 38.7 34.5 35.1 31.5 39.8 29.6 2.3E-11 1.29 1.20–1.39
rs10893872 11 ETS1 downstream 47.3 42.8 45.6 42.1 49.1 42.3 44.0 38.1 1.8E-7 1.21 1.13–1.31
rs7097397 10 WDFY4 Coding,
R1816Q
35.3 27.5 37.2 34.3 41.9 33.8 39.2 33.6 8.15E-12 1.30 1.21–1.40
rs877819 10 WDFY4 intron 23.4 16.4 17.3 18.6 28.3 22.2 20.6 17.3 5.57E-7 1.26 1.15–1.37
doi:10.1371/journal.pgen.1000841.t003
Table 4. ETS1 Haplotype analysis on SLE association.
rs10893872-rs1128334 F_A (%) F_U(%) P - Value
TA haplotype Hong Kong 40.35 33.2 5.89E-06
Anhui 36.99 28.51 1.25E-04
Bangkok 35.58 31.02 0.06
Shanghai 37.93 32.93 0.0023
CG haplotype Hong Kong 51.86 56.63 0.0035
Anhui 53.71 62.31 0.00022
Bangkok 50.76 57.28 0.0113
Shanghai 53.35 56.06 0.11
doi:10.1371/journal.pgen.1000841.t004
Figure 5. Allelic expression of ETS1 on SNP rs1128334 in PBMC
of healthy individuals. PBMC cDNA processed from 33 healthy
individuals heterozygous on rs1128334 were used for allelic expression
detection of ETS1 by pyrosequencing. (A) A case example of detection
on the ‘‘A’’ allele and the ‘‘G’’ allele from both DNA and cDNA samples
from the same individual. (B) The ratio of G/A allelic detection for both
DNA and cDNA samples. The median G/A ratio for DNA is 1.09 (95% CI:
1.08–1.11) and the median G/A ratio for cDNA expression is 1.32 (95%
CI: 1.21–1.43), P,0.0001 by paired student’s t test.
doi:10.1371/journal.pgen.1000841.g005
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characterized by high titers of IgM and IgG autoantibodies,
immune complex-mediated glomerulonephritis, and local activa-
tion of complement [29]. Ets-1 is also involved in many cellular
abnormalities that are known to participate in SLE pathogenesis as
illustrated in Figure 7.
Ets-1 is a negative regulator of terminal differentiation of B cells
and plays critical roles in maintaining B cell identity [30–32]. Ets-
1-deficient B cells were present in normal numbers but have a
large proportion of IgM plasma cells [33]. Ets-1 blocks the
function of B-lymphocyte-induced maturation protein 1 (Blimp-1),
an essential transcription factor for plasma cells [34]. The number
and frequency of plasma cells were known to correlate with disease
activity and the titer of anti-dsDNA antibodies in SLE [35,36].
Ets-1 is also a negative regulator of Th17 cell differentiation,
and naı ¨ve CD4
+ T cells deficient in Ets-1 undergo greatly
enhanced differentiation into Th17 cells when cultured in vitro
under Th17-skewing conditions [37]. Th17 cells with specificity
for self-antigens are known to be highly pathogenic and lead to the
development of inflammation and severe autoimmunity [38].
Higher plasma IL-17, IL-23 and higher number of Th17 cells in
SLE patients were reported and correlated positively with SLE
disease index (SLEDAI) [39–41]. IL-17 and IL-21 produced by
Th17 cells may also induce B cell terminal differentiation [42–44].
In this study, we found that in the PBMC of healthy individuals,
expression of ETS1 from the risk ‘‘A’’ allele is reduced comparing
to that from the ‘‘G’’ allele. The expression level of ETS1 may be
tightly regulated. It was shown that resting T cells express high
levels of ETS1 mRNA and protein, which decreased to very low
levels upon T cell activation [45]. Lower expression of ETS1 for
the risk allele carriers may play a role in disease pathogenesis
through increased differentiation and activity of both plasma cells
and Th17 cells.
It is likely that the association SNPs identified in this study may
affect the response of ETS1 gene to other upstream signals. SNP
rs1128334 locates in the 39-UTR of ETS1, and rs10893872 is in
absolute LD with rs4937333, another SNP that is also located in
the 39-UTR of the gene and both SNPs are on putative microRNA
(miRNA) binding sites. In a recent study by Du et al, the
expression level of a microRNA, miR-326, was found to be related
to disease severity in patients with multiple sclerosis and mice with
experimental autoimmune encephalomyelitis. ETS1 was shown to
be the major target of miR-326, through downregulation of which
miR-326 promoted the generation of Th17 cells both in vitro and in
vivo [46]. Another microRNA, miRNA-146a, was also found to be
involved in SLE pathogenesis [47].
WDFY family member 4 (WDFY4, NCBI GeneID: 57705)
codes for a huge protein (3184 amino acid residues) with unknown
function. Its closest paralog is WD repeat and FYVE domain
containing 3 (WDFY3, NCBI GeneID: 23001). Similar to WDFY3,
WDFY4 does contain WD40 domains and a BEACH (Beige and
chediak-kigashi) domain, although FYVE zinc finger domain is
truncated. Its sequence is well conserved among various species.
For example, there is an 84% sequence similarity between the
human protein and its orthologs from Bos Taurus and Canis lupus
familiaris. And there is a 42% identity between the human protein
and protein XP_701288.3 in Danio Rerio (zebra fish). Although
protein XP_701288.3 is annotated as WDFY3 in NCBI, it has a
higher sequence similarity with human WDFY4 than with
WDFY3.
WD40 domain is found in a number of eukaryotic proteins that
cover a wide variety of functions including adaptor/regulatory
modules in signal transduction, pre-mRNA processing and
cytoskeleton assembly, while the BEACH domains are implicated
in membrane trafficking. While very little is known about the
potential function of this well conserved protein, an interesting
phenomenon is that the gene is predominantly expressed in
immune tissues such as lymph node, spleen, thymus and tonsil
(UniGene Hs.287379, http://www.ncbi.nlm.nih.gov/UniGene/
ESTProfileViewer.cgi?uglist=Hs.287379), unlike WDFY3, which
is expressed in a wide variety of tissues and organs.
After submission of our work, Han et al reported their GWAS
work on SLE on Chinese populations [18] and reported genome-
wide significant association signals on ETS1 (rs6590330, down-
stream of the gene) and WDFY4 (rs1913517, in the intron of both
WDFY4 and LRRC18, leucine rich repeat containing 18).
Independent identification of these two genes in SLE susceptibility
underlined the validity of the findings. Identifying susceptibility
genes provided a good start in our effort to elucidate the disease
mechanisms and the functions of the genes involved, although
many questions remain to be answered. Characterization of the
functions of the genes in autoimmunity may eventually help us to
translate genetic findings into clinical and therapeutic applications.
Materials and Methods
Ethics statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The Hong Kong study was
approved by the Institutional Review Board of the University of
Hong Kong and Hospital Authority, Hong Kong West Cluster,
New Territory West Cluster, and Hong Kong East Cluster. The
study on Shanghai, Anhui and Thai samples was approved by the
Institutional Review Board of Renji Hospital, Research Ethics
Committee of Anhui Medical University and the Ethics Commit-
tee of the Faculty of Medicine, Chulalongkorn University,
respectively. All patients provided written informed consent for
the collection of samples and subsequent analysis.
Subjects
1073 SLE samples collected in Hong Kong were from four
hospitals in Hong Kong Island and the New Territories: Queen
Mary Hospital, Tuen Mun Hospital, Queen Elizabeth Hospital
and Pamela Youde Nethersole Eastern Hospital. The patients
Table 5. Replication of disease association for WDFY4 SNPs in the Hong Kong samples.
SNP Position to the gene BP A1 F_A F_U A2 CHISQ P OR
Rs2170132 Ser1528Pro 50013402 T 0.1679 0.1617 C 0.2793 0.5971 1.046
rs7097397 Arg1816Gln 50025396 G 0.3534 0.2753 A 2.88E+01 7.88E-08 1.438
rs877819 intron 50042951 A 0.2339 0.1639 G 3.12E+01 2.33E-08 1.557
Rs2292584 Pro3118Leu 50816415 T 0.3679 0.3416 C 3.075 0.0795 1.122
doi:10.1371/journal.pgen.1000841.t005
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The average onset age was 28 years old and the ratio of female to
male patients was 9:1. About half of the patients had renal
involvement, and about 70% tested positive for anti-dsDNA
antibodies. The SLE samples collected in Shanghai were patients
attending Renji Hospital of Jiaotong University Medical School, a
tertiary referral hospital covering Shanghai and the surrounding
areas. There is an 8:1 female to male patient ratio, and about 52%
of patients have lupus nephritis. 951 SLE patients collected in
Anhui were all self-reported Chinese ethnicity living in Anhui
province, central China. They were recruited from the Depart-
ments of Rheumatology at Anhui Provincial Hospital and the First
Figure 6. LD among WDFY4 SNPs examined in this study (A) and sequence conservation of the three nonsynonymous variations
among various species (B).
doi:10.1371/journal.pgen.1000841.g006
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Hefei, Anhui province, about 450 km from Shanghai. The
average onset age was 31 years old and the ratio of female to
male patients was 17:1. 314 Thai patients with SLE (female:male
ratio=14:1) attending King Chulalongkorn Memorial Hospital, a
tertiary referral center in Bangkok were also recruited in this study.
Medical records were reviewed to confirm that all subjects met the
revised criteria of the American College of Rheumatology for SLE
diagnoses [48].
Controls used in the GWAS stage were from both healthy
individuals and from other studies conducted in the same
institution genotyped with the same platform. For the replication
stage, Hong Kong controls were healthy blood donors kindly
contributed by the Hong Kong Red Cross and were all of self-
reported Chinese ethnicity living in Hong Kong. Controls from
Shanghai and Anhui were selected from a pool of healthy blood
donors recruited from Renji Hospital (Shanghai) and Hefei City
(Anhui), respectively, with an effort to match for the age and sex of
corresponding SLE patients. Thai controls were recruited from
unrelated voluntary healthy donors from the same ethnic
background and geographic area as the Thai SLE patients.
Genome-wide association study
320 (27 males, 293 females) SLE patients were genotyped by
Illumina 610-Quad Human Beadchip with a total number of SNPs
reaching 620,901. 24 individuals were removed due to low call rate
or hidden first degree relationship. A total number of 104,395 SNPs
were also removed from the initial analysis on the ground of low
genotyping call rate (,90%, 30,133 SNPs) and/or low minor allele
frequency (MAF) (,0.005, 102,970 SNPs). 2,285 SNPs were also
removed due to violation of Hardy-Weinberg equilibrium in
controls (P values,0.0001). After quality control measures, 314
case (27 males, 287 females) and 1484 controls (840 males and 644
females) were analyzed on a total of 514,221 SNPs. The call rate for
the remaining SNPs reached 0.999 with a genome-wide inflation
factor of 1.03, which is an indication of good match between the
cases and controls. To overcome any potential effect from the
heterogeneity in the controls, three independent comparisons were
initially conducted by separating the controls into three different
subsets and only SNPs reaching significance in all subsets in
association analysis were selected for further replication.
The SNPs were analyzed for association with the disease by
means of comparison of the minor allele frequency in patients and
controls (basic allelic test) as well as other tests using Plink [49].
Linkage disequilibrium (LD) patterns were analyzed and displayed
by HaploView [50]. Association of the SNPs with disease risk was
also corrected by logistic regression using age and sex as covariates.
Average odds ratios (OR) and P values jointly analyzed from four
sample collections were obtained by Cochran-Mantel-Haenszel
(CMH) test of disease association conditional on SNP frequency
differences among different populations. Test of independent
contributions of a SNP controlling for the effect of other SNPs in
the same locus was done by conditional logistic regression as well as
haplotype analyses. Subphenotype stratification was performed by
comparing cases with and without a given subphenotype.
Genotyping in replication stage
SNPs rs1128334, rs10893872, rs7097397, rs10857650, and
rs877819 were genotyped by TaqMan SNP genotyping method
using assay-on-demand probes and primers (Applied Biosystems,
Foster City, CA94404, USA). Some of the initial screening was
also done using Sequenom MassARRAY iPLEX Gold system.
Genotyping accuracy was confirmed by direct sequencing of PCR
products for some randomly chosen samples. Genotyping
concordance between Illumina Human 610-Quad Beadchip and
TaqMan SNP genotyping method was also examined on selected
samples and probes: rs877819 has a concordance rate of 99.64%
(1 out of 277 differed by the two platforms); rs10893872 has a
concordance rate of 99.16% (1 out of 119 samples differed). SNP
rs1128334 and rs7097397 were examined by direct sequencing of
selected samples and showed complete consistence between
TaqMan and sequencing (50 samples each). The results of
rs10857650 were discarded due to low concordance between the
Illumina Beadchip data and the TaqMan results.
Allele-specific transcription quantification
Thirty-three healthy individuals heterozygous for rs1128334
were chosen to assess the relative ETS1 mRNA levels from the two
alleles, ‘‘A’’ and ‘‘G’’, by pyrosequencing [51,52]. In the
meantime, DNA detection ratio was used as a control for
amplification efficiency. Briefly, total RNA was extracted from
peripheral blood mononuclear cell (PBMC) from each individual.
RNA samples were then treated with DNAase to eliminate
genomic DNA contamination before being reverse-transcribed
into cDNA using oligo-dT primer. cDNA was then amplified by
PCR using transcript-specific primers, together with DNA from
the same individuals. The cDNA and DNA PCR products were
purified using the Qiaquick PCR purification kit, and then
subjected to allele quantitative pyrosequencing. The sequencing
primer was designed using Pyrosequencing Assay Design Software
v.1.0. Reactions were performed on a Biotage PSQ96MA
machine, and allele quantification was analyzed using PSQMA
2.1 software. The average G/A cDNA expression ratio of each
individual was normalized by the G/A DNA ratio from the same
sample. Paired student’ t test was used to compare the normalized
expression level from the ‘‘A’’ and ‘‘G’’ alleles.
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